Drug: fluticasone propionate Quarter: 2016Q3
Total Drug/Injury Combinations: 112 Number of Pages: 6
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| Fluticasone propionate+salmeterol xinafoate | Feeling abnormal | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Gastrointestinal disorder | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Headache | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Insomnia | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Intentional product misuse | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Migraine | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Paraesthesia | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Respiratory tract infection | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Rib fracture | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Sinusitis | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Throat irritation | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Ulcer | 2 | view events |
| Fluticasone propionate+salmeterol xinafoate | Weight increased | 2 | view events |
| FLUTICASONE PROPIONATE. | Adrenal insufficiency | 2 | view events |
| FLUTICASONE PROPIONATE. | Cushing's syndrome | 2 | view events |
| FLUTICASONE PROPIONATE. | Haematochezia | 2 | view events |
| FLUTICASONE PROPIONATE. | Headache | 2 | view events |
| FLUTICASONE PROPIONATE. | Myopathy | 2 | view events |
| FLUTICASONE PROPIONATE. | Product substitution issue | 2 | view events |
| FLUTICASONE PROPIONATE. | Steroid withdrawal syndrome | 2 | view events |
Total Drug/Injury Combinations: 112 Number of Pages: 6
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)